Patents by Inventor aFRAXis, Inc.

aFRAXis, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PAK INHIBITORS FOR THE TREATMENT OF CANCER
    Publication number: 20130158043
    Abstract: Provided herein are methods of utilizing PAK inhibitors for the treatment of cancer. Further provided herein are compounds and formulations utilized for the treatment of cancer.
    Type: Application
    Filed: December 7, 2012
    Publication date: June 20, 2013
    Applicant: AFRAXIS, INC.
    Inventor: Afraxis, Inc.
  • PAK INHIBITORS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS
    Publication number: 20130116263
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of cell proliferative disorders and/or CNS disorders.
    Type: Application
    Filed: November 2, 2012
    Publication date: May 9, 2013
    Applicant: AFRAXIS, INC.
    Inventor: AFRAXIS, INC.
  • 8-ETHYL-6-(ARYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20130035335
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.
    Type: Application
    Filed: September 18, 2012
    Publication date: February 7, 2013
    Applicant: aFRAXis, Inc.
    Inventor: aFRAXis, Inc.